Cargando…
Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors
Human parainfluenza virus (hPIV) infections are a major cause of respiratory tract illnesses in children, with currently no available vaccine or drug treatment. The surface glycoprotein haemagglutinin-neuraminidase (HN) of hPIV has a central role in the viral life cycle, including neuraminic acid-re...
Autores principales: | Eveno, Tanguy, Dirr, Larissa, El-Deeb, Ibrahim M., Guillon, Patrice, von Itzstein, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563277/ https://www.ncbi.nlm.nih.gov/pubmed/31060278 http://dx.doi.org/10.3390/v11050417 |
Ejemplares similares
-
The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design
por: Dirr, Larissa, et al.
Publicado: (2017) -
A dual drug regimen synergistically blocks human parainfluenza virus infection
por: Bailly, Benjamin, et al.
Publicado: (2016) -
Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus
por: Yusoff, Khatijah, et al.
Publicado: (1988) -
Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza
por: Ward, Melissa J, et al.
Publicado: (2013) -
Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding
por: Lai, Jimmy Chun Cheong, et al.
Publicado: (2019)